pig; comparative genomics; innate immunity TYPE I IFNS are a family of cytokines prominent in antiviral responses. In contrast to a single type II IFN, i.e., IFN-␥, type I IFNs consist of multiple subclasses including IFN-␣, IFN-␤, IFN-ε, IFN-, and IFN- (16, 30) . Humans have multiple IFN-␣ subtypes and single-subtype subclasses of IFN-␤, IFN-ε, IFN-, and IFN- (42) . Type I IFNs also include other subclasses with a more limited species expression, including IFN-␣ (6), IFN-␦ (6, 20) , IFN-, and IFN-(limitin) (27) . Ubiquitously expressed IFN-␣ and IFN-␤ are among the most studied subclasses for antiviral responses. Although less extensively studied, tissue-and cell-specific expressed subclasses, such as IFN-in various leukocytes, IFN-␦ and IFN-ε in female reproductive tissues (6, 7, 20) , and IFN-in epidermal keratinocytes, are potently induced by viral infection and confer an antiviral state on uninfected cells (30, 42) . In pigs type I IFNs are known to consist of several multiple-subtype subclasses (IFN-␣, IFN-, and IFN-␦), and they also possess a single gene locus encoding IFN-␤ (3, 4, 6, 18, 25) . Although quite a few porcine type I IFN genes have been identified, information about the complete repertoire, gene structure, expression profiles, and comparative antiviral activity of most porcine type I IFNs is not available.
Type I IFNs, particularly IFN-␣ and IFN-␤, are central to antiviral innate immunity. Through a feedback loop of production and action, type I IFNs not only activate antiviral responses by autocrine means but also function systemically to induce an antiviral state in surrounding and distal cells. Induction of the antiviral state, which includes suppression of cellular metabolic processes and profound expression of antiviral IFN-stimulated genes (ISGs) (10, 45) , is critical for developing effective immune protection against viral infections. Hundreds of ISGs have been identified with various functions such as direct virus targeting, amplification of antiviral resistance, and sequestration of cellular metabolic processes to repress virus replication (35, 40) . The efficacy of induction of antiviral responses appears different between subclasses and even between subtypes belonging to the same subclass. For example, human IFN-␣ subtypes vary in their ability to activate human natural killer cells, and IFN-␤ shows more potency than IFN-␣2 in inhibition of monocyte proliferation (8, 41, 43) . Therefore, to elucidate the antiviral potency of a type I IFN family, it is essential to systematically analyze their antiviral activity among members of the same and different subclasses.
Here we report, based on the current understanding of the porcine genome, a near-complete analysis of the porcine type I IFN family consisting of 39 functional genes, classified into 7 subclasses distributed along draft genomic sequences of chromosomes 1 and 10. Several IFNs have been identified for the first time in this study, and others, which have appeared in the sequence literature but have not been functionally characterized, were evaluated for gene expression and antiviral activity. We show that members of different or the same porcine type I IFN subclasses have diverse expression profiles and antiviral activities against porcine reproductive and respiratory syndrome virus (PRRSV) and vesicular stomatitis virus (VSV) and that some newly identified IFNs have potent anti-PRRSV activity.
MATERIALS AND METHODS

Viruses and cells.
All virus procedures were approved by the Kansas State University (KSU) Biosafety committee. The PRRSV isolate was a cell culture-adapted strain, SDSU-23983-P140 (13, 34) . VSV (Indiana 1 serotype) was a natural isolate standardized for VSV diagnostic evaluations in the Kansas State Veterinary Diagnostic Laboratory (26) . MARC-145 cells, an African green monkey kidney cell line sensitive to PRRSV infection, PK-15 cells, a porcine circovirus-1-free subclone of the porcine kidney PK-15 cell line (American Type Culture Collection, Manassas, VA), and porcine primary alveolar macrophages (AMs), isolated and cultured as previously described (38) , were used as target cells to test IFN antiviral activity.
Procedures for cell culture, viral infection, and virus detection were conducted as previously described (37) (38) (39) .
Definition of porcine type I IFN sequences and phylogenic analysis. With the web-based algorithms tblastn, protein blast (http://blast. ncbi.nlm.nih.gov/Blast.cgi), and Genomview (http://www.ncbi.nlm. nih.gov/Tour/3a.html), putative porcine IFN sequences were extracted from working draft sequences deposited by the Swine Genome Project (GenBank accession nos. AC127471, AC130792, AC135219, AC138785, CU463237, CU469469, CU633414) and later refined with reference genome assemblies of Sscrofa5 (http://www.ncbi.nlm.nih. gov/projects/genome/guide/pig/index.html) and Sscrofa9 (http://www. sanger.ac.uk/Projects/S_scrofa/). Further confirmation of coding regions, sequence alignments, and phylogenic analysis was conducted by combined use of bioinformatic tools in EBI (http://www.ebi.ac.uk/ services/) and ExPASy (http://us.expasy.org/) as previously described (29, 36) .
IFN gene isolation and construction of expression constructs. Porcine cDNA was reverse transcribed from a pool of total RNA extracted from intestine, skin, and mesenteric lymph nodes with a SuperScript III First-Strand Synthesis System and random primers (Invitrogen, Carlsbad, CA) (37) . Coding regions of porcine IFNs were amplified from this cDNA pool for transcription confirmation and isolation of open reading frames (ORFs). Whole ORFs of some IFNAs and IFNK were isolated from porcine genomic DNA (Novagen, Madison, WI). A high-fidelity PCR AccuPrime Taq system (Invitrogen) with gene-specific or subtype-common cloning primers (Supplemental Table S1 ) was used.
1 PCR fragments of ORFs were purified and cloned into a pcDNA 3.3-TOPO TA cloning/expression vector (Invitrogen). An Applied Biosystems 3730 DNA Analyzer was used for sequencing IFN genes cloned in a pcDNA 3.3-TOPO TA vector with the vector sequencing primers (Invitrogen). At least five clones for each IFN gene were selected by gene-specific PCR and sequenced from both forward and reverse directions. Two or three clones with the highest sequence identity (98 -100%) to the template sequence extracted from working draft sequences deposited in the Swine Genome Project were selected for protein overexpression and antiviral assays. Plasmids for cell transfection were purified from individual bacteria cultures with an Endo-free plasmid purification kit (Sciresys, Cherry Hill, NJ).
PCR optimization and real-time RT-PCR analysis. Gene-specific or subtype-common primers were designed based on multiple alignments of related IFN sequences (Supplemental Table S1 ). Some primers and PCR conditions for IFN-␣ subtypes were derived from previous publications with modifications (4, 5) . Primers and PCR conditions were optimized and validated by using confirmed IFN plasmids to show specific amplification only with templates containing confirmed IFN clone(s). Tissues were obtained from healthy 5-wk-old crossbred pigs as previously described (36) . All collection procedures were approved by the Kansas State University Institutional Animal Care and Use Committee. Real-time RT-PCR arrays in a 96-well microplate format (iCycler5.0, Bio-Rad, Hercules, CA) were performed with the validated primers. Reactions were conducted with a SYBR Green RT-PCR system (Qiagen, Valencia, CA) with 150 ng of total RNA in a 25-l reaction mixture and RT-PCR conditions as described previously (36 cells/well in serum-free medium. The transfection procedure was the same as above but with a proportionally (15ϫ) increased transfection mixture for each well. IFN-containing supernatants and media from mock-transfected cells were collected separately at 72 h after transfection. Expressed IFNs were the major protein band in supernatants with protein concentrations of 5-10 g/ml (micro BCA protein assay kit, Pierce, Rockford, IL). IFN peptides were partially purified (Centricon centrifugal filters, 10k and 50k NMWL, Millipore, Billerica, MA), subjected to gel electrophoresis (NuPAGE Bis-Tris gel system, Invitrogen), and stained (Coomassie blue G-250 solution, Bio-Rad). Before use, protein concentrations in supernatants were adjusted to 2 g/ml (the lowest concentrations obtained in some subtypes) with serum-free medium. Supernatants were filtered (0.2 m) and stored at Ϫ135°C until use. In addition, total RNA was extracted from transfected HEK293F cells to examine the intensity and uniformity of the expression of transfected IFN genes by real-time RT-PCR as described above.
Antiviral and antiproliferative assays. Antiviral activity of IFNcontaining supernatants was assayed as the inhibition of cytopathic effect (CPE) of PRRSV and VSV on MARC-145 and PK-15 cells, respectively, as previously described (4) . In brief, cells were cultured in flat-bottom 96-well plates to 95% confluence, and 10 l of IFN-containing medium was added to each well with predispensed 90 l of fresh medium containing virus. Virus concentrations for infections were at a multiplicity of infection (MOI) of 0.1 and 0.2 50% tissue culture infectious dose (TCID50)/ml for PRRSV and VSV, respectively. Controls included medium collected from mock-transfected cells (MEM); medium collected from cells transfected with an antisense IFNA1 cloned in pcDNA3.3 vector; incubation of 50 l of IFN-␣1-or IFN-␤1-containing medium with 10 g of antibodies against porcine IFN-␣ (K9 clone, R&D Systems, Minneapolis, MN) or human IFN-␤ (R&D Systems), respectively (anti-␣ and anti-␤); and a standard curve (0 -250 U/100 l) of recombinant porcine IFN-␣ (3.8 ϫ 10 7 U/mg, catalog no. 17100-1, R&D Systems). At 48, 60, or 72 h after infection, protective activity of IFNs on virus infections was determined with crystal violet staining (PRRSV-and VSV-MARC-145 and VSV-PK-15) or immunofluorescence staining of PRRSV (PRRSV-AM) (38) . Images were collected with an AlphaImager (Alpha Innotech, San Leandro, CA) for crystal violet-stained plates. Quantitative data were obtained by measuring absorbance at 570 nm for dye extracts from crystal violet-stained wells (4) with an ELISA microplate reader or calculating percentages of virus-positive cells for immunofluorescence-labeled viruses. Percent protection of an IFN was calculated with the formula 100 ϫ (Vt Ϫ Vi)/(Vt Ϫ V0), where Vt represents the value of total/highest occurrence of a viral infection in untreated cells, Vi is the value obtained from IFN-treated cells, and V0 is the value from cells without addition of virus. All Vt or V0 values were averages of data from 8 or 16 replicate wells transformed with one or two IFN polymorphic clones. To titrate antiviral activity, 10-fold serial dilutions of IFN-containing medium were assayed with the PRRSV-MARC-145, VSV-MARC-145, and VSV-PK-15 virustarget cell systems. Antiviral activity was calculated by the ReedMuench method (31), with 1 unit as the highest dilution that reduced cell number by 50%.
The antiproliferative assay was performed by adding serial dilutions of IFN to MARC-145 cells in flat-bottom microtiter plates and monitoring cell density after 72 h by crystal violet staining. The 50% activity concentrations (EC 50) of IFN were determined from an IFN dose-response curve (SigmaPlot11.0, Systat, Chicago, IL) as described by Roisman et al. (32) .
Promoter-reporter systems for interferon-stimulated genes. Promoter regions corresponding to human IFN regulatory factor-3 (IRF-3, Ϫ779/ϩ1) (21), IRF-7 (Ϫ1123/ϩ575) (22) , and MxA (Ϫ530/ ϩ1) (33) were retrieved from human genomic DNA (Invitrogen) with a high-fidelity PCR kit (Invitrogen). Promoter regions were cloned into luciferase reporter vector pGL4.14 [luc2/Hygro] (Promega, Madison, WI) with the KpnI and HindIII cloning sites (37) . Sequenceconfirmed constructs were used to transfect MARC-145 cells and to establish stable reporter cell lines after selection of surviving cell colonies after 10 passages in medium containing 500 g/ml hygromycin B (Invitrogen). All three promoter-reporter MARC-145 cell lines used were tested numerous times for their responses to virusrelated stimuli (37) and recombinant IFN-␣ (R&D Systems). Cells were grown to confluence on 96-well plates and then incubated with IFN-containing media for 16 h. Cells were lysed, and released luciferase was detected simultaneously by addition of a Steady-Glo luciferase assay reagent at 100 l/well (Promega, Madison, WI). After incubation for 10 min at 22°C, luciferase activity was measured with a luminometer (Fluoroskan, Ascent, FL). Statistical analyses were done with SigmaPlot 11.0 software (Systat).
Nucleotide sequence accession numbers. Nucleotide sequences for the new identifications, characterizations, and sequences in this article have been deposited in GenBank. Accession numbers are listed in Table 1 .
RESULTS
Repertoire and phylogenic analysis of porcine type I IFNs.
To investigate the repertoire of porcine type I IFNs, we used bioinformatic tools to scan swine genome databases (http://www. (3), and AC138785 (4)] and 3 unordered porcine genome working draft sequences [GenBank accession nos. CU463237 (5), CU469469 (6) , and CU633414 (7)]. Annotated loci are locations of genes (including untranslated regions and ORF) that were annotated in the reference genome assembly of Sus scrofa autosome 1 (SSC1). Subtypes IFNA1-IFNA14 were designated according to Cheng et al. (4) , whereas IFNAW, IFNB, IFND1-IFND11, IFNE, and IFNK were designated according to Cochet et al. (6) and Krause and Pestka (15) . IFNW1, IFNW3, and IFNW7 matched to 3 functional genes of porcine IFN-␣-II4, -II5, and -II3, respectively, as characterized by Mege et al. (25) . Additional members of IFNW and IFNA newly annotated in this study were designated thereafter. *IFND2 and IFND7 are potentially pseudogenes (P) with premature termination related to ORF translation. ncbi.nlm.nih.gov/genome/guide/pig/). At least 38 porcine type I IFN gene loci were clustered densely in 6 regions spanning ϳ10 -20 kb each along Sus scrofa autosome 1 (SSC1). These regions of SSC1 are covered by working draft sequences with GenBank accession numbers AC127471, AC130792, AC135219, AC138785, CU469469, and CU633414 deposited by the Swine Genome Project. These 38 loci likely encode most of the porcine type I IFNs and include genes of 17 IFN-␣ subtypes, 11 IFN-␦ subtypes, 7 IFN-subtypes, and single-subtype subclasses of IFN-␣, IFN-␤, and IFN-ε. In addition, we correlated most of these type I IFN loci with putative annotations on pig reference genome assembly Sscrofa5 (Table 1 ). The gene of another singlesubtype subclass, IFN-, is located on porcine chromosome 10 (SSC10) spanned by the working draft sequence with accession number CU463237. Additional evidence of the IFNK location was found by searching the draft assembly of SSC10 at PreEnsembl (http://www.ensembl.org/Sus_scrofa/index.html). The location of the IFNK gene was defined in a region of SSC10 between 37,587,861 and 37,588,487 bp on the reverse strand with a transcript ID of ENSSSCT00000012053. Gene loci of the three single-subtype IFN subclasses are generally separated from other IFN genes by greater than ϳ30 kb. In contrast, each IFN locus of multiple-subtype subclasses (i.e., IFNA, IFND, and IFNW genes) was within ϳ20 kb distance from other closest IFN gene loci (Supplemental Fig. S1 ).
Among all identified porcine type I IFNs, the IFNK gene has the longest ORF (627 bp) encoding a 208-amino acid peptide. All other genes of porcine type I IFNs distributed on SSC1 have ORFs of 462-582 bp, encoding prepeptides of 153-193 amino acids (Supplemental Fig. S1 ). Examination of predicted peptides of all porcine type IFNs against the conserved domain database (CDD; http://www.ncbi.nlm.nih.gov/Structure/cdd/ cdd.shtml) indicates that they all contain an IFabd functional domain, which is a type I IFN signature (24) . Multiple putative binding sites for type I IFN receptor (IFNAR) subunits and one putative N-glycosylation site (Asn/Asp-X-Ser/Thr), which are important for IFN signaling and IFN peptide stability, were also detected in all porcine IFN peptides. All 39 porcine IFNs bear NH 2 -terminal 20-to 30-amino acid signal peptides. Except for IFN-␦7, all porcine IFN peptides have two conserved cysteine residues, the second Cys 52 and fourth Cys 162 relative to IFN-␣1 (Fig. 1) . However, the other two cysteine residues (the IFN-␦1 ). Within the IFabd domain of each IFN isoform, five regions that may conform into five ␣-helixes were found, except for IFN-␦7, which only has the first four helical regions (Fig. 1) . The three multiple-subtype subclasses (IFN-␣, IFN-␦, and IFN-) can be further subclassified into short and long members within each subclass. The major difference is that the long members have 6 -16 extended residues forming a COOHterminal positively charged or hydrophobic tail. For example ,  IFN-␣4, IFN-␣5, IFN-␣6, IFN-␣8, IFN-␣9, IFN-␣12, IFN (Fig. 1) . The four single-subtype subclasses (IFN-␣, IFN-␤, IFN-ε, and IFN-) have a COOH-terminal positively charged or hydrophobic tail of 6, 6, 11, and 7 residues, respectively. In the IFN-␣ subclass, this COOHterminal positively charged or hydrophobic tail is thought to contribute to higher antiviral activity in the long isoforms (41) .
Phylogenic classification of porcine type I IFNs in this study was based on the following criteria. First, sequence similarity of subtypes within a subclass is near or higher than 80% nucleic acid or 60% amino acid, and sequence similarity of subtypes between subclasses is lower than 70% nucleic acid or 50% amino acid. Second, multiple subtypes of each subclass generally share the same cysteine distribution and likely intramolecular disulfide bond patterns, even though some distribution patterns may be conserved among subclasses. For example, subtypes of IFN-␣ and IFN-have four cysteine residues likely forming two intramolecular disulfide bonds as in human IFN-␣2a (14) , and IFN-␤ has two cysteine residues likely forming one disulfide bond as in human IFN-␤ (12). Third, names of each subclass were based on their closest homologs within or across species in previous references. To this end, porcine IFN-␤ (3) and IFN-␣ (mostly IFN-␣1) (18) were previously isolated, and IFN-␣1 to IFN-␣14 and several IFN-␦ subtypes were recently defined by bioinformatic analyses (4, 6); IFN-ε, IFN-, and some isoforms of IFN-␣ (IFN-␣15, IFN-␣16, IFN-␣17) were characterized for the first time in this study. Two to three subtypes of IFN-␦ or IFN-were originally reported as short type I porcine interferon (SPI-IFN) or porcine IFN-␣II (PoIFN-␣II) (18 -20, 25) . Recently, eight IFN-were defined in the porcine genome with a similar bioinformatic approach. However, identical sequences were shared in pairs of IFN-2/6 and IFN-3/5; thus those eight IFN-reflect six of the IFN-designated here (44) . IFN-␣, first coined by Krause and Pestka (15) during an evolutionary analysis of IFNs, is a unique isoform that has only been identified in a few species such as pigs and cattle. Relative to other IFNs, IFN-␣ shows only 65% nucleic acid identity and 50% amino acid similarity to the closest subclass. Similar to IFN-␤, it has a six-amino acid tail.
Phylogenic analysis shows that each porcine IFN subtype is in the same subclade with the same subclass from other mammalian species, such as IFN-␣, IFN-␤, IFN-ε, IFN-, and IFN-of humans. Exceptions are the porcine IFN-␣ and IFN-␦ subclasses, where no human ortholog has been identified (Fig. 2) . IFN-␣ is located at a branch separated from IFN-␣ and IFN-subtypes, to which it has highest sequence similarity (ϳ65% nucleic acid and 50% amino acid). In addition to Ͼ60% amino acid similarity to orthologs from other species, porcine IFN-subtypes and IFN-␦1/4 also have ϳ40% amino acid similarity to bovine IFN-(6) and murine IFN-, respectively (27, 42) .
Differential expression of porcine type I IFNs. Although sharing high sequence similarity in coding ORFs, the putative promoter regions among most members of porcine type I IFNs are quite different (Y. Sang, unpublished observation). This suggests that expression of type I IFN genes even within a subclass is different in respect to tissue/cell types or different stimuli. We thus devised an assay to detect the differential expression of most porcine type I IFN genes with a real-time RT-PCR array. As shown in Table 2 , significant expression of multiple-type IFN genes was detected in skin, intestine, lymph nodes, spleen, and testis. For example, in skin, 15 IFN genes belonging to all subclasses were highly expressed, with a relative expression index higher than 1.00. IFN genes were highly expressed in intestine (10 genes) and lymph nodes (9 genes); however, most of them were from subclasses other than IFN-␣. In spleen and testis two to four IFN genes from each multiple-subtype subclass (i.e., IFN-␣, IFN-␦, or IFN-) were highly expressed. In contrast, bone marrow cells and liver showed a relatively weaker expression pattern of type I IFNs. Relative to subtype differences, IFN-␣1, IFN-␣8, and IFN-␣12 and IFN-␤ were detected in all tested tissues. Although shown to have tissue and cell preference in some of their orthologs, porcine IFN-␦8 and IFN-␦5/6; IFN-1, IFN-2, and IFN-3; and single-subtype subclasses IFN-ε and IFN-were detectable in most tested tissues and highly expressed in three or four assayed tissues. IFN-␣ was highly expressed only in skin, although detectable in intestine, lymph nodes, and spleen.
Antiviral activity of expressed IFNs. For our initial evaluation of antiviral activity of porcine IFNs two approaches were used: 1) direct transfection of MARC-145 cells with IFN expression constructs and 2) treatment of MARC-145 cells with IFN-containing medium collected from transfected HEK293A cells (Supplemental Fig. 2A ). Antiviral protection of expressed IFN genes or IFN-containing medium was shown by decreasing the ability of PRRSV to produce CPE on cell monolayers. Alignment of data from both expression vector transfection and IFN-containing medium treatment showed similar characteristics between the two activity curves (r 2 ϭ 0.95; Supplemental Fig. 2A) . The protective effect of exogenous IFN was specific, because media from mock transfection of cells with an antisense IFNA1-pcDNA construct did not protect against viral infection. In addition, incubation of IFNcontaining medium from either IFN-␣1 or IFN-␤ with antibodies to porcine IFN-␣ or IFN-␤ (anti-␣ or anti-␤, respectively) eliminated the anti-PRRSV activity (Supplemental Fig. 2B ). For the purpose of comparison, incubation with commercial recombinant porcine IFN-␣ showed that concentrations Ͼ31 U/100 l of IFN-␣ were sufficient to fully protect MARC-145 cells from PRRSV infection (Supplemental Fig. 2B ). Collectively, these findings showed that IFN peptides expressed by transfected porcine IFN genes conferred antiviral activity in the cells, and that IFN-containing medium collected from transformants could be used to determine the antiviral activity of transformed porcine IFN genes. Therefore, we further purified and concentrated IFN peptides from the IFN-containing medium (Supplemental Fig. S3) , and protein concentrations of all IFN supernatants were measured for further evaluation of IFN activity.
The protective role of IFN-containing medium against viral infection was evaluated in both porcine cells and MARC-145 cells. In both porcine AMs and MARC-145 cells, all IFN-␣ subtypes, except IFN-␣7 and IFN-␣11 (a guanosine-deletion mutant of IFN-␣7/11), provided nearly full protection against PRRSV infection (10 3 dilution, ϳ2 ng/ml; Fig. 3A ). In contrast, other subtypes, including IFN-␤ and most IFN-␦ and IFN-, showed effective protection (60 -80%) against PRRSV in porcine AMs but not in MARC-145 cells (Fig. 3A) . Porcine type I IFN antiviral activity against VSV in PK-15 and MARC-145 cells displayed similar activity profiles, i.e., most IFN-␣ subtypes exerted antiviral activity in both porcine and MARC-145 cells, but other subtypes were selectively active in porcine cells (Fig. 3B) . Interestingly, IFN-␣, a unique porcine IFN subtype, exerted higher antiviral protection in MARC-145 cells than in porcine cells (Fig. 3) . In all evaluations, IFN-␣7, IFN-␣11, IFN-␦2, IFN-␦7, IFN-ε, IFN-, and IFN-4 showed little antiviral activity against PRRSV or VSV in either porcine cells or MARC-145 cells (Fig. 3) .
On the basis of further analysis of antiviral activity against PRRSV and VSV, porcine type I IFNs were categorized into high-and low-activity groups (Fig. 4) . Members in the high-activity groups were those having average activity higher than 5 ϫ 10 3 U·ng Ϫ1 ·ml Ϫ1 . In MARC-145 cells, the high-activity group exhibited a range of anti-PRRSV activity of 10 4 to Ͼ10 5 U·ng Ϫ1 ·ml Ϫ1 and included most members of the IFN-␣ subclass tested (except IFN-␣7 and IFN-␣11) and IFN-␣. The highest-activity subtype, IFN-␣6, provided full antiviral protection in the PRRSV-MARC-145 system at ϳ0.02 ng/ml. Members in the lowactivity groups had activity near or at 0 U·ng Ϫ1 ·ml Ϫ1 . The Fig. 2 . Phylogenic relationship of porcine type I interferons (poIFNs) and identified human (hu) and bovine (bo) orthologs. The analysis is based on predicted amino acid sequences. GenBank accession numbers for poIFNs are listed in Table 1 . GenBank accession numbers for huIFNs and boIFN are huIFN-␣1, NP_076918; huIFN-␣6, NP_066282; huIFN-␣17, NP_067091; huIFN-␤, NP_002167; huIFN-ε, NP_795372; human-, NP_064509; huIFN-, NP_002168; and boIFN-␣, XP_001254773.
low-anti-PRRSV activity group included the three singlesubtype subclasses (IFN-␤, IFN-ε, and IFN-), all members of tested IFN-␦ and IFN-, and IFN-␣7 and IFN-␣11 (Fig.  4B) . The anti-PRRSV activity of porcine IFNs in MARC-145 cells was comparable to the anti-VSV activity in both MARC-145 and PK-15 cells (Fig. 4, C-F) . Although most active IFNs showed higher anti-VSV activity than anti-PRRSV activity in MARC-145 cells, the profiles of the high-and low-activity groups were similar to that categorized above (Fig. 4, C and D) . Exceptions included IFN-␦8, which was the lowest active member in the high-anti-VSV activity group (Fig. 4C) , and IFN-␦1 and IFN-␤ in the low-activity group that had some activity, but not different from the negative controls (Fig. 4D) . Anti-VSV activity in porcine PK-15 cells was unlike that obtained in MARC-145 cells (Fig. 4, E and F) . The high-anti-VSV activity group in BMC, bone marrow cells; Intestine, duodenum fragment; MLN, mesenteric lymph nodes. Tissues were obtained from healthy 5-week-old crossbred pigs as previously described (36) . PK-15 cells not only included all IFN-␣ subtypes but also IFN-␤, four IFN-␦ (␦1, ␦4, ␦5, and ␦6), and IFN-2 (Fig.  4E) . IFN-␣, which had high activity in MARC-145 cells, had low anti-VSV activity in PK-15 cells and was categorized in the low-activity group along with 11 other porcine IFNs (Fig. 4F) . Gel electrophoresis of IFN-containing samples confirmed the presence of correct proteins of both highand low-activity IFNs, such as IFN-␣7 and other IFN-␣ subtypes (Supplemental Fig. S3 ). In addition, some IFNs that are minimally active in MARC-145 exerted antiviral activity in porcine cells (Fig. 3) , indicating that the absence of activity of an IFN was not caused by the protein in an inactive form. IFN alone was not responsible for cell death because antiproliferative activity of porcine IFNs required much higher concentrations than that required for antiviral activity (Supplemental Table S2 ).
Anti-PRRSV activity of porcine type I IFNs correlates with activation of MxA. IRFs and the MxGTPase pathway are main effector pathways for IFN-meditated antiviral responses. To investigate the signaling pathways of porcine type I IFNs, promoters for IRF-3, IRF-7, and MxA were transfected into MARC-145 cells. Comparison of anti-PRRSV activity of porcine type I IFNs against activation of IFN-stimulated genes showed that antiviral activity was highly correlated (r 2 ϭ 0.97) with an IFN's ability to induce MxA promoter activity (Fig. 5A) . A lower correlation was found between IFN antiviral potency and stimulation of IRF-7 promoter activity (Fig. 5B ). In contrast, almost no correlation existed between anti-PRRSV activity and the ability of porcine type I IFNs to stimulate the IRF-3 promoter (Fig. 5C ).
DISCUSSION
Continuing progress of animal genome projects and the use of functional genomic approaches have expanded and given definition to several mammalian gene families (29, 36) . This study provides experimental support for three new findings concerning the porcine type I IFN family. First, it shows that the porcine type I IFN family consists of 39 functional genes, classified into 7 subclasses. Second, it identifies for the first time seven new porcine IFNs and provides new functional analyses for many others. Third, it shows that some newly identified and functionally characterized porcine IFNs are differentially expressed and have potent anti-PRRSV activity.
Porcine type I IFN gene loci consist of at least 39 single-exon (intronless) functional genes, spanning an ϳ500-kb region of SSC1 with an IFN-positioned on SSC10. The finding of a porcine IFNK locus on a different chromosome than other type I IFNs was unexpected because its human ortholog is located on the same chromosome (chromosome 9) as other type I IFN genes (42) . Further searching of the draft assembly of SSC10 refined the annotated location of this gene. In addition, a radiation hybrid map of SSC10 refined a syntenic region to HSA9 at 27-99 Mb, which might contain the human IFNK gene locus, indicating a possible chromosome relocation of porcine IFNK compared with its human ortholog (23) .
Of the known porcine IFNs, IFN-␣1 (presumably) and IFN-␤ are among the most characterized subtypes, including their molecular identification and antiviral responses related to multiple viral infections (3, 4) . Other subtypes have received less, but some, characterization. For example, porcine IFN-␦ subtypes were originally designated as small porcine IFNs, and IFN-␦1 was well defined for its expression in trophoblasts (19) . In addition, three functional porcine IFN-genes that were originally designated as IFN-␣-II4, -II5, and -II3 and characterized by Mege et al. in 1991 (25) were matched to our IFNW1, IFNW3, and IFNW7, respectively. In this study, seven porcine IFNs have been identified for the first time (IFN-␣15, IFN-␣16, and IFN-␣17, IFN-ε, IFN-, and IFN-2 and IFN-7), and others, which have appeared in the sequence literature but have not been characterized (6, 15, 19) , were evaluated for antiviral activity. Each porcine IFN gene has a 500-to 600-bp ORF, which encode a peptide contain- We examined differential expression of most type I IFN genes in several porcine tissues. Because these tissues were from healthy pigs without symptoms of disease, we reasoned that the expression data represent basal levels of these innate immune antiviral effectors in these tissues. A preliminary expression analysis in PRRSV-positive porcine tissues has shown differences from basal expression in control tissues (Y. Sang, unpublished observation).
Different IFNs possessed diverse activities when tested in different target cell-virus systems; therefore, porcine IFNs were categorized into high-and low-activity groups according to their anti-PRRSV or anti-VSV activities in MARC-145 cells (Fig. 4, A-D) . Generally, porcine IFNs were more active in porcine cells (Figs. 3 and 4 ). An intriguing exception is IFN-␣, which was more active in MARC-145 cells than in porcine cells. Recombinant porcine IFN-␣ (presumably IFN-␣1) and IFN-␤ have been shown to suppress PRRSV infectivity in AMs (2, 28) . Our data further indicate that most subtypes of the IFN-␣ subclass are highly active against PRRSV in both porcine AMs and MARC-145 cells; however, other subclasses including IFN-␤, IFN-␦, IFN-ε, and IFN-are minimally active in MARC-145 cells. This likely reflects a difference between homologous and heterologous IFN ligand-receptor interaction. Work by others indicates that IFN-␣ is downregulated in response to PRRSV infection (1, 2, 9 ). This suggests that IFN-␣ subtypes should be emphasized in modulation of porcine anti-PRRSV innate immunity. This point is supported by findings showing that PRRSV isolates differ in their sensitivity to IFN-␣ suppression (17) . Therefore, extensive investigation of effective anti-PRRSV IFN scenarios may uncover critical aspects that shape efficient immune protection to PRRSV infection. Antiviral activity of porcine type I IFNs in MARC-145 cells is correlated with their ability to induce expression of MxA rather than IRF-3 and IRF-7. This indicates that the efficacy of an IFN to signal downstream ISG expression may contribute more to anti-PRRSV activity than to autoregulating IFN production. Alternatively, some ISGs, like MxA, may have special PRRSV-targeting activity (40) .
We have shown that most subtypes of the porcine IFN-␣ subclass were very active against PRRSV in in vitro systems. Why then are these IFNs not effective in mitigating PRRSV infection? Answers to this question are not known; however, two reasonable answers are possible: 1) endogenous IFN concentrations are lower than the in vitro overexpressed concentration and 2) stimulation of systemic antiviral immunity in vivo may require multiple type I IFNs. More defined analyses of overexpressed and endogenous IFNs at the protein level should help to answer these questions and to elucidate porcine IFN antiviral innate immunity.
In summary, we have identified an expanded repertoire of porcine type I IFNs through bioinformatic annotation and extensive comparative antiviral assays. Elucidation of most of the active IFN molecules and downstream ISG candidate(s) against PRRSV will help clarify porcine anti-PRRSV immunity and may suggest novel strategies to limit costly pandemic viral disease.
